A patent review of adaptor associated kinase 1 (AAK1) inhibitors (2013-present)

Taylor and Francis Group, Expert Opinion on Therapeutic Patents, 10(31), p. 911-936, 2021

Journal article published in 2021 by Belén Martinez-Gualda, Dominique Schols

, Steven De Jonghe

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by